商业化与创新
我们做什么
The 商业化 and innovation team identify and commercialise new technologies developed by our 研究ers so that business, 工业和社会都能从中受益.
确定易胜博体育
进入市场
势
安全的投资者
和资金
谈判
商业交易
形式衍生公司/
创业公司
教育和
导师
把想法变成现实
我们看到了一个充满潜力的世界——充满了伟大的想法, waiting for the right opportunities and the right people to turn them into bigger, 更好的事情.
作为澳大利亚领先的研究型大学之一, 我们汇集了业界最优秀的人才, 研究, 和学术界. 我们的专家团队, 最先进的设施和有影响力的联系能力, 我们可以帮助您在市场上获得竞争优势.
有计划目的的研究
We work with 研究ers assisting them to create groundbreaking discoveries and solutions.
We have developed this 研究 影响帆布 to help 研究ers crystallise their 研究.
为什么易胜博体育?
麦考瑞大学在创新方面表现出色. 我们的研究ers have been responsible for groundbreaking discoveries and solutions that have changed the world. Brilliant ideas with global potential do not come along every day; however, 新软件, 方法, 发明, 麦格理不断产生新的发现和技术.
有关改变世界的合作机会，请查阅我们的 可用的技术.
知识产权指导原则
Our imperative is to add value to the 研究 our 研究ers pursue and to make our 研究 partnerships as efficient and effective as possible.
创新框架
We know that 研究 has the potential to make significant contributions that benefit society. Read about the steps we are taking to maximise the potential of our innovation pipeline.
成功的故事
We are committed to producing successful market outcomes from collaboration between our 研究ers and commercial clients. 以下是我们帮助创造的一些成功故事.
你如何参与其中?
我们的专家
John Golding，商业化和创新临时总监
John started his career as a biomedical 研究 scientist working in both publicly funded 研究 roles as well as gaining experience in the early days of Australia’s biotech industry, before moving into 商业化 activities as a Licensing Development Manager with Sydnovate, 悉尼大学的商业部门. 从2007年开始，他担任专利 & Watermark(现Griffith Hack)的商标律师, 巴克斯特的IP, 最近, Krouzer IP, where he providing strategic advice on intellectual asset management for local and foreign clients, 同时也提供专利和商标方面的服务.
约翰于2021年开始在麦考瑞大学工作, 担任研究创新合同经理. 自2022年9月起，他担任临时董事, 商业化和创新办公室.
T: +61 (2) 9850 2299 | M: 0400 392 245
E: 约翰.golding@wuxijuhui.com
Gorjana Mitic，商业化和创新经理(生命科学)
Gorjana joined Macquarie University as a 商业化与创新 Manager (Life Sciences) in January 2018. She works closely with 研究ers in life sciences and medicine to assess innovative technologies and facilitate their translation and 商业化 through strategic partnerships, 授权和行业合作.
在此角色之top, she was a Business Development Manager at a biotechnology 商业化 consultancy Bio-Link Australia for 4 years. She worked with biotechnology and pharmaceutical companies and Medical 研究 Institutes to develop IP and 商业化 strategy, 确保易胜博体育关系，协商许可协议. She also provided comprehensive reviews of regulatory, competitive and IP landscapes.
Prior to receiving her PhD at the Children’s Cancer Institute from the University of NSW (Faculty of Medicine), Gorjana以一等荣誉获得理学士学位(生物技术). Her PhD thesis investigated new molecular targets in glioblastoma, a devastating brain cancer. In 2013, Gorjana was awarded a prestigious Women in Cancer 研究 Scholar Award. 同时, Gorjana obtained a Diploma of Innovation Management at UNSW focusing on the biotechnology industry, 商业化, 技术转让和知识产权管理. She served as an active committee member and a UNSW student representative of the AusBiotech Student Association for several years.
她目top是桥梁项目的导师和校友, a government and industry supported training program for science 商业化 and pharmaceutical drug development.
Gorjana also represents Macquarie University and MQ Health as a member of the Medical 研究 Commercialisation Fund (MRCF) Investment 研究 Committee.
Gorjana has an extensive industry network and loves creating opportunities for 研究ers to collaborate with industry. 为创新的科学发现和令人信服的数据而激动, Gorjana is always pleased to assist 研究ers and find ways towards translation and impact.
T:
E: 目top休假，请发邮件 ip@wuxijuhui.com.
莉安·普莱斯，行政官员
T: +61 2 9850 2251
E: 琳恩.price@wuxijuhui.com
知识产权投资组合经理Bel Coppock
Bel has a diverse background in events, regional marketing, customer service and patent management. Bel is responsible for keeping the 商业化和创新办公室 organised. She also liaises with Macquarie University's existing pool of inventors and administers royalty payments.
Contact Bel if you have any questions about 商业化 process at Macquarie.
T: +61 (2) 9850 4598
E: 贝琳达.coppock@wuxijuhui.com
Gabi Teli，知识产权投资组合官
P: +61 2 9850 4489
E: 加比.teli or ip@wuxijuhui.com
内容所有者: 商业化与创新 最后更新:2022年12月20日上午11:12